- Home
- PWM vs OSRH Comparison
PWM vs OSRH Comparison
Compare PWM & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWM
- OSRH
- Stock Information
- Founded
- PWM 2018
- OSRH N/A
- Country
- PWM Hong Kong
- OSRH United States
- Employees
- PWM N/A
- OSRH N/A
- Industry
- PWM
- OSRH
- Sector
- PWM
- OSRH
- Exchange
- PWM Nasdaq
- OSRH Nasdaq
- Market Cap
- PWM 12.4M
- OSRH 11.1M
- IPO Year
- PWM 2023
- OSRH N/A
- Fundamental
- Price
- PWM $0.59
- OSRH $0.58
- Analyst Decision
- PWM
- OSRH
- Analyst Count
- PWM 0
- OSRH 0
- Target Price
- PWM N/A
- OSRH N/A
- AVG Volume (30 Days)
- PWM 1.1M
- OSRH 13.8M
- Earning Date
- PWM 02-13-2026
- OSRH 08-14-2025
- Dividend Yield
- PWM N/A
- OSRH N/A
- EPS Growth
- PWM N/A
- OSRH N/A
- EPS
- PWM N/A
- OSRH N/A
- Revenue
- PWM $639,912.00
- OSRH $104,735.00
- Revenue This Year
- PWM N/A
- OSRH N/A
- Revenue Next Year
- PWM N/A
- OSRH N/A
- P/E Ratio
- PWM N/A
- OSRH N/A
- Revenue Growth
- PWM 83.60
- OSRH N/A
- 52 Week Low
- PWM $0.31
- OSRH $0.45
- 52 Week High
- PWM $2.70
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- PWM 71.45
- OSRH 41.12
- Support Level
- PWM $0.50
- OSRH $0.74
- Resistance Level
- PWM $0.64
- OSRH $1.24
- Average True Range (ATR)
- PWM 0.08
- OSRH 0.11
- MACD
- PWM 0.01
- OSRH 0.01
- Stochastic Oscillator
- PWM 80.11
- OSRH 15.50
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.